Skip to Main Content

Author Details

Adrian L Harris
University of Oxford
1981
1117
171
PMIDPaper TitleJournal TitlePublished Year
3672591975th anniversary of the British Journal of Cancer.Br J Cancer2023
37865002Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.J Neurol Sci2023
37635223Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.J Exp Clin Cancer Res2023
37844085A Rab6 to Rab11 transition is required for dense-core granule and exosome biogenesis in Drosophila secondary cells.PLoS Genet2023
37563220Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities.Br J Cancer2023
37046583Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model.Cancers (Basel)2023
37280675Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.J Exp Clin Cancer Res2023
37339186A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.Clin Cancer Res2023
37398109Lysine 117 on ataxin-3 modulates toxicity in <i>Drosophila</i> models of Spinocerebellar Ataxia Type 3.bioRxiv2023
37463466GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner.Cancer Res2023
36697317Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer.Clin Genitourin Cancer2023
36872252Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formation.J Extracell Vesicles2023
36765769Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus.Cancers (Basel)2023
36733939Clinical and molecular significance of the RNA m<sup>6</sup>A methyltransferase complex in prostate cancer.Front Genet2023
36733922Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in <i>Drosophila</i> models of Spinocerebellar Ataxia Type 3.Front Neurosci2023
34402068Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function.J Clin Pharmacol2022
35581637Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism.Breast Cancer Res2022
35764612Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.Cell Death Dis2022
36429023Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor.Cells2022
36460466Corrigendum: MEF2 transcription factors are key regulators of sprouting angiogenesis.Genes Dev2022
36038791Obesity: a perfect storm for carcinogenesis.Cancer Metastasis Rev2022
36297536Drug-Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer.Pharmaceutics2022
36263323Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.Front Endocrinol (Lausanne)2022
36291932The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.Cancers (Basel)2022
36010908Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast.Cancers (Basel)2022
36187346A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.Front Mol Neurosci2022
35127740Investigations on Zinc Isotope Fractionation in Breast Cancer Tissue Using <i>in vitro</i> Cell Culture Uptake-Efflux Experiments.Front Med (Lausanne)2022
35150959Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis.Neoplasia2022
35108535Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions.Cell Rep2022
32569822Dissecting the heritable risk of breast cancer: From statistical methods to susceptibility genes.Semin Cancer Biol2021
33597271Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.Clin Cancer Res2021
33731442The Landscape of the Heritable Cancer Genome.Cancer Res2021
33893326Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling.Sci Rep2021
33916413Unveiling Cancer Metabolism through Spontaneous and Coherent Raman Spectroscopy and Stable Isotope Probing.Cancers (Basel)2021
34950575Comprehensive Imaging Characterization of Colorectal Liver Metastases.Front Oncol2021
34910918The onset of circulation triggers a metabolic switch required for endothelial to hematopoietic transition.Cell Rep2021
35002323Partial Breast Reconstruction with Lateral Chest Wall Perforator Flap to Facilitate Breast Conservation in Breast Cancer: First 100 Cases with Cancer Outcomes at 8 Years Follow-Up and the Lessons Learned.Cancer Manag Res2021
34782604Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers.NPJ Breast Cancer2021
34681953ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.Int J Mol Sci2021
34353313Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs.BMC Cancer2021
33964942Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.J Exp Clin Cancer Res2021
34348993ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.Mol Cancer Res2021
34155340Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.Br J Cancer2021
34344457The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer.Cancer Metab2021
33945502Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.JCI Insight2021
33028955Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer.Br J Cancer2021
33398023Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer.Commun Biol2021
33414541Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast.Br J Cancer2021
32591342Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits.J Med Genet2021
32536008FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.Cancer Sci2020
  • 1 - 50 of 1,117

Recommended Authors

The University of Manchester
Career Start Year 2001
Number of shared co-authors 10
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 3
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 2
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 3
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 7
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 4
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 10
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 14
University of California Riverside
Career Start Year 1992
Number of shared co-authors 0
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 22
Oncology R&D
Career Start Year 1992
Number of shared co-authors 9
12 University College London Hospitals National Health Service Foundation Trust
Career Start Year 1989
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 24
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 13
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 2
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 1
University of Bern
Career Start Year 1985
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 11
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 1
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 5
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 3
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 6
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 8
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 13
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 26

Collaborators

University of Oxford
Co-authored papers 74
Co-authored papers 28
Institute of Cancer Research
Co-authored papers 23
University of Manchester
Co-authored papers 19
McGill University
Co-authored papers 18
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 12
Co-authored papers 12
National Institute for Health Research Biomedical Research Centre
Co-authored papers 9
University of Oxford, John Radcliffe Hospital
Co-authored papers 8
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 7
Co-authored papers 7
Medical University of Vienna
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Co-authored papers 5
Maastricht University
Co-authored papers 5
Co-authored papers 4
Leeds Teaching Hospitals NHS Trust, University of Leeds
Co-authored papers 4
MRC Oxford Institute for Radiation Oncology & Biology, University of Oxford
Co-authored papers 4
Medical University of Vienna
Co-authored papers 4
The Institute for Cancer Research
Co-authored papers 4
College of Agriculture and Life Sciences, Cornell University
Co-authored papers 4
Mount Vernon Cancer Centre
Co-authored papers 4
Co-authored papers 4
Indiana University School of Medicine
Co-authored papers 4
GE Global Research Center
Co-authored papers 4
Co-authored papers 3
Universityhospital Frankfurt
Co-authored papers 3